NCT01493219View on ClinicalTrials.gov

Biomarkers for Prognosis of Glioblastoma (GBM)

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

September 20, 2011

Primary Completion Date

September 1, 2017

Study Completion Date

September 1, 2017

Conditions
Glioblastoma
Trial Locations (1)

68198

University of Nebraska Medical Center, Omaha

All Listed Sponsors
lead

University of Nebraska

OTHER

NCT01493219 - Biomarkers for Prognosis of Glioblastoma (GBM) | Biotech Hunter | Biotech Hunter